Sort by
Items per page

Send to

Choose Destination

Best matches for O’Shaughnessy MM[au]:

Search results

Items: 26


Percutaneous Kidney Biopsy and the Utilization of Blood Transfusion and Renal Angiography Among Hospitalized Adults.

Charu V, O'Shaughnessy MM, Chertow GM, Kambham N.

Kidney Int Rep. 2019 Jul 23;4(10):1435-1445. doi: 10.1016/j.ekir.2019.07.008. eCollection 2019 Oct.


Prevalence of Cardiovascular Disease Risk Factors in Childhood Glomerular Diseases.

Ashoor IF, Mansfield SA, O'Shaughnessy MM, Parekh RS, Zee J, Vasylyeva TL, Kogon AJ, Sethna CB, Glenn DA, Chishti AS, Weaver DJ, Helmuth ME, Fernandez HE, Rheault MN; CureGN Consortium.

J Am Heart Assoc. 2019 Jul 16;8(14):e012143. doi: 10.1161/JAHA.119.012143. Epub 2019 Jul 9.


Long-term low-dose corticosteroids for maintenance of remission in ANCA vasculitis: Friend or foe?

O'Shaughnessy MM.

Clin Nephrol. 2019 Apr;91(4):195-199. doi: 10.5414/CN109566. No abstract available.


Confidence in Women's Health: A Cross Border Survey of Adult Nephrologists.

Hendren EM, Reynolds ML, Mariani LH, Zee J, O'Shaughnessy MM, Oliverio AL, Moore NW, Hill-Callahan P, Rizk DV, Almanni S, Twombley KE, Herreshoff E, Nester CM, Hladunewich MA.

J Clin Med. 2019 Feb 3;8(2). pii: E176. doi: 10.3390/jcm8020176.


Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study.

Selewski DT, Ambruzs JM, Appel GB, Bomback AS, Matar RB, Cai Y, Cattran DC, Chishti AS, D'Agati VD, D'Alessandri-Silva CJ, Gbadegesin RA, Hogan JJ, Iragorri S, Jennette JC, Julian BA, Khalid M, Lafayette RA, Liapis H, Lugani F, Mansfield SA, Mason S, Nachman PH, Nast CC, Nester CM, Noone DG, Novak J, O'Shaughnessy MM, Reich HN, Rheault MN, Rizk DV, Saha MK, Sanghani NS, Sperati CJ, Sreedharan R, Srivastava T, Swiatecka-Urban A, Twombley K, Vasylyeva TL, Weaver DJ, Yin H, Zee J, Falk RJ, Gharavi AG, Gillespie BW, Gipson DS, Greenbaum LA, Holzman LB, Kretzler M, Robinson BM, Smoyer WE, Flessner M, Guay-Woodford LM, Kiryluk K; CureGN Consortium.

Kidney Int Rep. 2018 Aug 3;3(6):1373-1384. doi: 10.1016/j.ekir.2018.07.021. eCollection 2018 Nov.


A large, international study on post-transplant glomerular diseases: the TANGO project.

Uffing A, Pérez-Sáez MJ, La Manna G, Comai G, Fischman C, Farouk S, Manfro RC, Bauer AC, Lichtenfels B, Mansur JB, Tedesco-Silva H, Kirsztajn GM, Manonelles A, Bestard O, Riella MC, Hokazono SR, Arias-Cabrales C, David-Neto E, Ventura CG, Akalin E, Mohammed O, Khankin EV, Safa K, Malvezzi P, O'Shaughnessy MM, Cheng XS, Cravedi P, Riella LV.

BMC Nephrol. 2018 Sep 12;19(1):229. doi: 10.1186/s12882-018-1025-z.


Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis.

O'Shaughnessy MM, Liu S, Montez-Rath ME, Lafayette RA, Winkelmayer WC.

Eur Heart J. 2019 Mar 14;40(11):887-898. doi: 10.1093/eurheartj/ehy422.


Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey.

O'Shaughnessy MM, Hogan SL, Thompson BD, Coppo R, Fogo AB, Jennette JC.

Nephrol Dial Transplant. 2018 Apr 1;33(4):661-669. doi: 10.1093/ndt/gfx189.


Corticosteroids for IgA Nephropathy: TESTING for Benefit, Discovering Harm.

O'Shaughnessy MM, Lafayette RA.

JAMA. 2017 Aug 1;318(5):429-431. doi: 10.1001/jama.2017.9359. No abstract available.


Pregnancy Outcomes in Patients with Glomerular Disease Attending a Single Academic Center in North Carolina.

O'Shaughnessy MM, Jobson MA, Sims K, Liberty AL, Nachman PH, Pendergraft WF.

Am J Nephrol. 2017;45(5):442-451. doi: 10.1159/000471894. Epub 2017 Apr 27.


Temporal and Demographic Trends in Glomerular Disease Epidemiology in the Southeastern United States, 1986-2015.

O'Shaughnessy MM, Hogan SL, Poulton CJ, Falk RJ, Singh HK, Nickeleit V, Jennette JC.

Clin J Am Soc Nephrol. 2017 Apr 3;12(4):614-623. doi: 10.2215/CJN.10871016. Epub 2017 Mar 21.


Kidney Transplantation Rates Across Glomerulonephritis Subtypes in the United States.

OʼShaughnessy MM, Liu S, Montez-Rath ME, Lafayette RA, Winkelmayer WC.

Transplantation. 2017 Oct;101(10):2636-2647. doi: 10.1097/TP.0000000000001657.


Validating identification of patients with small vessel vasculitis, with or without renal involvement, using administrative healthcare records.

O'Shaughnessy MM, Cheng XS, Montez-Rath ME, Lafayette RA, Winkelmayer WC.

Clin Nephrol. 2017 Mar;87 (2017)(3):159-162. doi: 10.5414/CN109035. No abstract available.


Distinguishing the Signals From the Noise: Can Epidemiologic Studies Inform Our Understanding of Glomerular Disease?

O'Shaughnessy MM, Hogan SL.

Am J Kidney Dis. 2016 Oct;68(4):503-507. doi: 10.1053/j.ajkd.2016.05.009. No abstract available.


Kidney Transplantation Outcomes across GN Subtypes in the United States.

O'Shaughnessy MM, Liu S, Montez-Rath ME, Lenihan CR, Lafayette RA, Winkelmayer WC.

J Am Soc Nephrol. 2017 Feb;28(2):632-644. doi: 10.1681/ASN.2016020126. Epub 2016 Jul 18.


Differences in Initial Hemodialysis Vascular Access Use Among Glomerulonephritis Subtypes in the United States.

O'Shaughnessy MM, Montez-Rath ME, Zheng Y, Lafayette RA, Winkelmayer WC.

Am J Kidney Dis. 2016 Apr;67(4):638-47. doi: 10.1053/j.ajkd.2015.11.019. Epub 2016 Jan 8.


Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA.

O'Shaughnessy MM, Montez-Rath ME, Lafayette RA, Winkelmayer WC.

Nephrol Dial Transplant. 2016 Feb;31(2):290-8. doi: 10.1093/ndt/gfv386. Epub 2015 Nov 25.


Measuring comorbidity in patients receiving dialysis: can we do better?

O'Shaughnessy MM, Erickson KF.

Am J Kidney Dis. 2015 Nov;66(5):731-4. doi: 10.1053/j.ajkd.2015.07.001. Epub 2015 Jul 23. No abstract available.


Patient characteristics and outcomes by GN subtype in ESRD.

O'Shaughnessy MM, Montez-Rath ME, Lafayette RA, Winkelmayer WC.

Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1170-8. doi: 10.2215/CJN.11261114. Epub 2015 Jun 19.


Prevention of sudden cardiac death in hemodialysis patients.

O'Shaughnessy MM, O'Regan JA, Lavin PJ.

Cardiovasc Hematol Disord Drug Targets. 2014;14(3):195-204. Review.


C3 glomerulopathy: clinicopathologic features and predictors of outcome.

Medjeral-Thomas NR, O'Shaughnessy MM, O'Regan JA, Traynor C, Flanagan M, Wong L, Teoh CW, Awan A, Waldron M, Cairns T, O'Kelly P, Dorman AM, Pickering MC, Conlon PJ, Cook HT.

Clin J Am Soc Nephrol. 2014 Jan;9(1):46-53. doi: 10.2215/CJN.04700513. Epub 2013 Oct 31.


Blood pressure measurement in peritoneal dialysis: which method is best?

O'Shaughnessy MM, Durcan M, Kinsella SM, Griffin MD, Reddan DN, Lappin DW.

Perit Dial Int. 2013 Sep-Oct;33(5):544-51. doi: 10.3747/pdi.2012.00027. Epub 2013 Apr 1.


Re-infection following sustained virological response with a different hepatitis C virus genotype: implications for infection control policy.

O'Shaughnessy MM, O'Regan JA, Murray FE, Connell JA, Duffy MP, Francis VM, Dwyer S, Thornton LM, Conlon PJ.

Clin Kidney J. 2012 Jun;5(3):250-3. doi: 10.1093/ckj/sfs040. Epub 2012 Apr 18.


Sudden cardiac death in dialysis: do current guidelines for implantable cardioverter defibrillator therapy apply to patients with end-stage kidney disease?

O'Shaughnessy MM, Lappin DW, Reddan DN.

Semin Dial. 2012 May;25(3):272-6. doi: 10.1111/j.1525-139X.2012.01067.x. Epub 2012 Mar 27.


In-office assessment of blood pressure in chronic kidney disease: usual measurement versus automated BpTRU measurement.

O'shaughnessy MM, Newman CA, Kinsella SM, Reddan DN, Lappin DW.

Blood Press Monit. 2011 Jun;16(3):124-8. doi: 10.1097/MBP.0b013e328346e0db.


Effect of low dose aspirin on thrombus formation at arterial and venous microanastomoses and on the tissue microcirculation.

Peter FW, Franken RJ, Wang WZ, Anderson GL, Schuschke DA, O'Shaughnessy MM, Banis JC, Steinau HU, Barker JH.

Plast Reconstr Surg. 1997 Apr;99(4):1112-21.


Supplemental Content

Loading ...
Support Center